News

Shares of TreeHouse Foods Inc. (NYSE: THS) are branching out to new heights as the stock approaches a buy point, and is already actionable.  

Illinois-based Treehouse specializes in private-label

Shares of Mullen Automotive (NASDAQ: MULN) are down another 15% to trade back at the pre-split level near $.25. That’s a bitter pill to swallow for investors holding out hopes this company can

The Boeing Company (NYSE: BA) is one of the shining stars of the Dow Jones companies in 2023. The stock is up 16% as we approach the midpoint of 2023. This continues a rally that has pushed BA

Value investing is the idea of buying high-quality stocks when they are cheap. The hard part about value investing is buying those stocks when they’re down. Usually, stocks are down for a reason

Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock

The price-to-earnings ratio, or P/E ratio, is one of the most commonly used metrics in fundamental stock analysis. The division of share price by earnings per share (typically over the last 12

Unity Software (NYSE: U) saw its share price rocket higher Monday afternoon and closed the day up almost 20% after Apple (NASDAQ: AAPL) announced they are working together on the Apple Vision Pro

The way the institutions are flocking to values like Kohl’s (NYSE: KSS), Verizon (NYSE: VZ), and Walgreens Boots Alliance (NYSE: WBA), investors might begin to think the sell-side is preparing for

Shares of Verizon (NYSE: VZ) have been shedding value for more than 2 years, and that trend could continue, but there are a growing number of signs that suggest the bottom is in. Among them is the

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Nvidia Co. (NASDAQ: NVDA) CEO Jensen Huang sparked market whispers this week, hinting at enlisting Intel Co. (NASDAQ: INTC) to produce chips. Huang told reporters that Nvidia is "open to

Regarding steak marinades and financial debt, reductions are good — but not so much with stock dividends.

A board of director's decision to employ dividend cuts is usually motivated by a need to

Robots choosing your food? Say it ain’t so!

It may not be quite that futuristic (or dystopian, depending on your viewpoint), but Symbotic Inc. (NASDAQ: SYM) posted gains for six months in a row

It has become clear that AI mania is the investment theme du jour. The fortunes of semiconductor stocks surged in recent months, fueled by the AI boom and the increasing demand for advanced

Mobileye Global Inc. (NASDAQ: MBLY) is showing signs life, reminiscent of the iconic scene from "Monty Python's Life of Brian" where a character declares, "I’m not dead yet!"

After a selloff

CXApp Inc. (NASDAQ: CXAI) shares have been caught up in the artificial intelligence (AI) mania. On no news, its shares spiked to $21 on April 23, 2023, and have been melting since. The AI bug has

UiPath Inc. (NASDAQ: PATH) shares took an initial dive on its fiscal Q1 earnings release. The culprit was lowered fiscal Q2 2024 revenue guidance that spooked investors. However, the company

Nvidia CEO Jensen Huang calls ChatGPT's November 2022 release the AI industry's "iPhone moment," triggering an arms race among tech firms, big and small. Microsoft quickly bought half of OpenAI

With the AI boom in full swing, many investors are looking to chip makers as the companies that will proverbially sell picks and shovels in the AI gold rush. The thinking goes that the companies

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Administration (FDA). The company submitted, and

Sometimes when looking at a stock’s chart, you can actually when investors disagree with a selloff. That’s the case with Arista Networks Inc. (NYSE: ANET), which sold off hard after its

Pfizer Inc. (NYSE: PFE) released the results of a peer review study that sent shares up more than 5%. The study evaluated the company’s GLP-1 receptor agonist, danuglipron. The compound aimed to

Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like a Microsoft Co. (NASDAQ: MSFT) owned